文献速递免疫规划

加拿大哈特派儿童流感疫苗效力与免疫原性的性别差异

Sex-differences in influenza vaccine efficacy and immunogenicity among Canadian Hutterite children.
PubMed 文献 · Vaccine · 2025-12-12

本研究分析2008至2017年三项整群随机试验中加拿大哈特派6月龄至15岁儿童的数据,比较不同流感疫苗方案下流感发病率与免疫原性的性别差异。结果显示各试验中疫苗效力和免疫原性均无一致的性别差异,但试验1(以非流感疫苗为对照)存在疫苗与性别的效应修饰。作者认为性别可能不是儿童疫苗反应的主要因素,但在以非流感疫苗为对照的流感疫苗试验中更易被检出。

要点

  • 三项整群随机试验中,流感疫苗效力和免疫原性均无一致的性别差异。
  • 试验1中观察到疫苗与性别的效应修饰,该试验以非流感疫苗为对照。
  • 免疫原性指标(GMT、GMFR、SCR)的性别差异很少达到统计学显著。

核心结论

  • 作者认为性别可能不是儿童疫苗反应的主要因素,但在以非流感疫苗为对照的流感疫苗试验中更可能被检出。

研究设计与样本

  • 分析三项整群随机试验(2008至2017年)中加拿大哈特派6月龄至15岁儿童的数据。
  • 试验1比较三价流感疫苗(TIV)与甲型肝炎疫苗;试验2比较减毒活流感疫苗与TIV;试验3比较佐剂三价流感疫苗与四价流感疫苗。
  • 按性别评估各试验组内流感发病率,采用Cox比例风险模型调整性别、年龄和干预组,并按社区聚类,评估疫苗与性别的效应修饰。
  • 免疫原性采用血凝抑制(HAI)抗体反应,以几何平均滴度(GMT)、几何平均倍数升高(GMFR)和血清转化率(SCR)表示。

主要发现

  • 所有试验中,疫苗效力和免疫原性均无一致的性别差异。
  • 试验1(以非流感疫苗为对照)中观察到疫苗与性别的效应修饰。
  • 免疫原性结果显示GMT、GMFR或SCR中很少存在统计学显著的性别差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sex-differences in influenza vaccine efficacy and immunogenicity remain inconclusive, with limited evidence in pediatric populations. Hutterite communities provide a unique environment for evaluating vaccine responses due to their controlled social and environmental conditions. Understanding sex-differences could help inform targeted vaccination strategies. METHODS: This study analyzed data from three cluster-randomized trials (2008-2017) involving Canadian Hutterite children aged 6 months to 15 years. Participants received season-specific influenza vaccines across different seasons (Trial 1: trivalent influenza vaccine (TIV) versus hepatitis A vaccine); Trial 2: live attenuated influenza vaccine versus TIV; Trial 3: adjuvanted trivalent influenza vaccine versus quadrivalent influenza vaccine). Influenza incidence was assessed within trial groups by sex and vaccine efficacy was assessed using Cox proportional hazards models, adjusting for sex, age, and intervention group, with clustering by colony, and effect modification of vaccine by sex. Immunogenicity was measured using hemagglutination inhibition (HAI) antibody responses expressed as geometric mean titers (GMT), geometric mean fold rise (GMFR), and seroconversion rates (SCR). RESULTS: Across all trials, there were no consistent sex differences in either vaccine efficacy or immunogenicity. In Trial 1 however, there was effect modification of sex by vaccine in a trial with non-influenza vaccine control group. Immunogenicity results also revealed few statistically significant sex-differences in GMT, GMFR, or SCR. CONCLUSIONS: These findings suggest that sex may not be a major factor in vaccine response in pediatric populations, but may be more likely to be detected in influenza vaccine trials with a non-influenza vaccine control group.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Caswell C, Pullenayegum E, Singh P, et al. Sex-differences in influenza vaccine efficacy and immunogenicity among Canadian Hutterite children. Vaccine. 2025. PMID: 41389704. doi:10.1016/j.vaccine.2025.128102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。